CollPlant to reduce workforce by 20%

CollPlant (CLGN) recently updated its expense forecast and has initiated a cost cutting and workforce reduction plan. CollPlant’s updated allocation of resources is expected to result in a reduction in CollPlant’s workforce by approximately 20% and based on current estimates, allow it to continue its business activities including those related to its primary research and development programs until at least the second quarter of 2026. Tal added, “In 2025 CollPlant will focus its activities on advancing the development of its product candidate pipeline, including the development of the regenerative breast implant product candidate towards the clinical phase. I look forward to providing updates on our programs throughout the year.”